Scienture (NASDAQ:SCNX) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Scienture (NASDAQ:SCNX) from a sell rating to a hold rating in a report published on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

Scienture Stock Performance

Shares of SCNX stock opened at $0.53 on Friday. The firm’s 50 day moving average price is $0.57 and its two-hundred day moving average price is $1.01. Scienture has a 52-week low of $0.46 and a 52-week high of $5.16. The stock has a market cap of $21.53 million, a PE ratio of -0.53 and a beta of 3.00.

Scienture (NASDAQ:SCNX) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.19) earnings per share for the quarter. The firm had revenue of $0.59 million during the quarter.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.